Hinge Health's Q4 revenue tripled expectations, outlook exceeds consensus, stock soars

LootboxPhobia · 2026-02-14T04:21:35+00:00

Hinge Health announced a Q4 adjusted earnings of $0.49, well above analysts' expectations of $0.14, with the stock rising 3.5%. The company's revenue increased 46% year-over-year, and it expects future revenue to exceed market expectations. The number of customers and members has increased significantly, and the financial position remains solid.

LootboxPhobia

2026-02-14 04:21:35

Abstract generation in progress

Investing.com – Hinge Health, Inc. (NYSE: HNGE) announced on Tuesday that its fourth-quarter adjusted earnings were three times higher than analyst expectations, and provided guidance above consensus, causing its stock to rise 3.5% in after-hours trading.

The digital musculoskeletal care provider reported a fourth-quarter adjusted earnings of $0.49 per share, significantly exceeding analyst estimates of $0.14. Revenue grew 46% year-over-year to $170.7 million, up from $117.3 million in the same period last year. The company’s non-GAAP operating revenue increased 124% to $48 million, more than doubling compared to the previous year.

Hinge Health co-founder and CEO Daniel Perez stated, “We closed the quarter with excellent performance and a strong sales season, driving the highest win rate to date and the largest increase in qualified lives in any year.”

Looking ahead, Hinge Health provided an optimistic outlook for 2026. For the first quarter, the company expects revenue between $171 million and $173 million, above the consensus estimate of $159.7 million. For the full year 2026, Hinge Health forecasts revenue of $732 million to $742 million, surpassing analyst expectations of $700.4 million.

The company reported strong customer growth, with the number of customers increasing 25% year-over-year to 2,830, and contract lives expanding from $20 million a year ago to $25 million. Memberships surged 47% to 782,890.

As of December 31, 2025, Hinge Health maintained a solid cash position with $478.8 million in cash, cash equivalents, marketable securities, and restricted cash. Free cash flow grew 65% to $61.5 million, compared to $37.3 million in Q4 2024.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.